Update on risks associated with paternal exposure to valproate
The EMA have provided an update on their ongoing assessment of a paper on the risks of paternal exposure to valproate.
News
New survey on SUDEP awareness launched – we need your feedback!
In advance of SUDEP Action Day on October 18th, we are seeking responses to an important survey aimed at understanding the awareness of SUDEP amongst the epilepsy community.
EI urge Government Action on Implementation of IGAP on Epilepsy & other Neurological Conditions
In advance of the International Epilepsy Congress, Epilepsy Ireland have called on the Government to become global leaders in regard to the implementation of the WHO Intersectoral Global Action Plan on Epilepsy and other neurological conditions.
Wayne is a Golden Light!
Later this week, Wayne O'Reilly will be awarded with a Golden Light award in recognition of his contributions to epilepsy awareness!
We want YOUR feedback!
We have issued a very important survey aimed at understanding the experiences of all those who engage with Epilepsy Ireland. Can you help us by providing your feedback?
We're Hiring - will you be our new Fundraising & Development Executive?
We are currently hiring for the position of Fundraising & Development Executive to join our fundraising team.
Increasing and diversifying our income to help continue our journey towards a society where no person’s life is limited by epilepsy is a key strategic aim for our organisation. This is an important position within our team to achieve this aim.
Oireachtas Committee recommends extension of Free Travel scheme to people with epilepsy
Read about a recent development which has further amplified our longstanding campaign to improve access to the Free Travel scheme for people with epilepsy.
Epilepsy Ireland AGM 2023
The Annual General Meeting of Brainwave, The Irish Epilepsy Association (trading as Epilepsy Ireland) for the year ending 31.12.22 was held on July 6th via zoom.
Statement from OACS Ireland and Epilepsy Ireland on cabinet approval for non-statutory inquiry into historical licensing and prescribing of Sodium Valproate
Last week, the Government approved the holding of an inquiry into the historical licensing and prescribing of Sodium Valproate. Read our response to this important development.
Study provides further information on how CBD may prevent seizures.
A study recently published in the medical journal Neuron, has providing further information on how cannabidiol (CBD) works to potentially prevent seizures.
CBD is a non-psychoactive component of the cannabis plant, meaning that it does not cause the ‘high’ associated with recreational use of cannabis. In recent years, numerous studies have been carried out on the use of CBD treatments in drug-resistant epilepsies – many of which have showed positive findings.